NCT07660510尚未招募不适用
Evolution of Different Sensitivity Levels in Patients With Chronic Neuropathic Pain in the Pelvi-perineal Region After Treatment With High-concentration Capsaicin Patches
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
The primary objective of this study will be to demonstrate a change in pain sensitization parameters before and after the application of the high-concentration capsaicin patch.
详细描述
Category 2 Study (Interventional Research with Minimal Risks and Constraints), monocentric, uncontrolled, non-randomized, open-label and prospective.
This study involves conducting tests and questionnaires before and 1 month after the application of a patch administered as part of standard clinical practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men or women ≥ 18 years old.
- •Patients suffering from chronic pelvi-perineal neuralgia (>3 months) with a DN4 score ≥4 at the inclusion visit, with or without symptoms of central sensitization, and with an indication for topical treatment with high-concentration capsaicin patch (PCHC).
- •Patients who have signed the informed consent form for the study at the inclusion visit.
- •Women must meet one of the following criteria at the time of inclusion:
- •Use adequate contraceptive measures;
- •or Be postmenopausal (aged over 50 years with amenorrhea for at least 12 months after discontinuation of all exogenous hormonal treatments);
- •or (If aged under 50 years) have been amenorrheic for at least 12 months after discontinuation of exogenous hormonal treatments, with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels consistent with postmenopausal levels;
- •or Have undergone irreversible surgical sterilization (hysterectomy, bilateral oophorectomy, or bilateral salpingectomy), with documentation of the procedure.
排除标准
- •Patients under guardianship, curatorship, or legal protection.
- •Pregnant or breastfeeding women.
- •Patients with contraindications to the use of the high-concentration capsaicin patch (PCHC): application on damaged skin, hypersensitivity to any of its components.
- •Patients simultaneously starting a treatment that may influence central sensitization (e.g., antidepressants, antiepileptics, psychotherapy, physical activity, transcutaneous electrical nerve stimulation).
- •Patients not affiliated with the French Social Security system.
- •Patients with insufficient cooperation and/or understanding to strictly comply with the protocol requirements.
- •Patients who have taken analgesics within the 12 hours prior to measurements.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Central Sensitization and Clinical Parameters in Chronic Neck PainNCT07462416Turkoglu Dr. Kemal Beyazit State Hospital84
尚未招募
不适用
Central Sensitization in Painful and Painless Diabetic Peripheral NeuropathyNCT07316322Inonu University128
进行中（未招募）
不适用
Central Sensitisation in Nociceptive and Neuropathic PainNCT07321080IRCCS Centro Neurolesi Bonino Pulejo185
尚未招募
不适用
Pain measurement in chronic pain patients and to correlate with autonomic functionsCTRI/2025/04/084103Government Medical College and Hospital30
Unknown
不适用
帕金森病疼痛易感性的临床及基础研究ChiCTR2400082297自筹